About the Authors
- Sabine Hagemann
-
Affiliation Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Germany
- Dirk Kuck
-
Affiliations Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Germany, Global Drug Discovery, Bayer Healthcare Pharmaceuticals, Berlin, Germany
- Carlo Stresemann
-
Affiliation Global Drug Discovery, Bayer Healthcare Pharmaceuticals, Berlin, Germany
- Florian Prinz
-
Affiliation Global Drug Discovery, Bayer Healthcare Pharmaceuticals, Berlin, Germany
- Bodo Brueckner
-
Affiliation Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Germany
- Cora Mund
-
Affiliation Global Drug Discovery, Bayer Healthcare Pharmaceuticals, Berlin, Germany
- Dominik Mumberg
-
Affiliation Global Drug Discovery, Bayer Healthcare Pharmaceuticals, Berlin, Germany
- Anette Sommer
-
* E-mail: anette.sommer@bayer.com
Affiliation Global Drug Discovery, Bayer Healthcare Pharmaceuticals, Berlin, Germany
Competing Interests
Sabine Hagemann and Bodo Brueckner were employees of the German Cancer Research Center. Dirk Kuck is employee of the German Cancer Research Center. Carlo Stresemann, Florian Prinz, Cora Mund, Dominik Mumberg, and Anette Sommer are employees of Bayer Healthcare Pharmaceuticals. Dirk Kuck was an employee of Bayer Healthcare Pharmaceuticals. The work was performed within the Strategic Alliance between Bayer Healthcare and the German Cancer Research Center (DKFZ). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SH DK CS FP CM DM AS. Performed the experiments: SH DK CS FP BB CM AS. Analyzed the data: SH DK CS FP CM DM AS. Contributed reagents/materials/analysis tools: DK FP CM. Wrote the paper: SH DK CS AS. Contributed to the Affymetrix Array Northern database: AS.